000 01596 a2200373 4500
005 20250516021635.0
264 0 _c20110725
008 201107s 0 0 eng d
022 _a1934-2403
024 7 _a10.4158/EP10282.CR
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFerrer-García, Juan C
245 0 0 _aEverolimus resolving hypoglycemia, producing hyperglycemia, and necessitating insulin use in a patient with diabetes and nonresectable malignant insulinoma.
_h[electronic resource]
260 _bEndocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
_c
300 _ae17-20 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAged
650 0 4 _aDiabetes Mellitus, Type 2
_xdrug therapy
650 0 4 _aEverolimus
650 0 4 _aHumans
650 0 4 _aHyperglycemia
_xchemically induced
650 0 4 _aHypoglycemia
_xdrug therapy
650 0 4 _aImmunosuppressive Agents
_xtherapeutic use
650 0 4 _aInsulin
_xtherapeutic use
650 0 4 _aInsulinoma
650 0 4 _aMale
650 0 4 _aSirolimus
_xanalogs & derivatives
700 1 _aTolosa-Torréns, Mercedes
700 1 _aHernando-Meliá, Cristina
700 1 _aArribas-Palomar, Luis
700 1 _aSánchez-Juan, Carlos
773 0 _tEndocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
_gvol. 17
_gno. 2
_gp. e17-20
856 4 0 _uhttps://doi.org/10.4158/EP10282.CR
_zAvailable from publisher's website
999 _c20530036
_d20530036